243 related articles for article (PubMed ID: 26463745)
1. Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis.
Kaukinen A; Pelkonen J; Harvima IT
Eur J Dermatol; 2015; 25(6):548-55. PubMed ID: 26463745
[TBL] [Abstract][Full Text] [Related]
2. CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas.
Haimakainen S; Kaukinen AP; Suttle MM; Pelkonen J; Harvima IT
Cancer Invest; 2017 Mar; 35(3):143-151. PubMed ID: 28267402
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers.
Kaukinen A; Siiskonen H; Pelkonen J; Harvima IT
Eur J Dermatol; 2017 Dec; 27(6):590-598. PubMed ID: 29165303
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
5. Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas.
Rahkola D; Laitala J; Siiskonen H; Pelkonen J; Harvima IT
Cancer Invest; 2019; 37(2):73-84. PubMed ID: 30689427
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
7. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation.
Carvalho RF; Nilsson G; Harvima IT
Exp Dermatol; 2010 Feb; 19(2):117-22. PubMed ID: 19889021
[TBL] [Abstract][Full Text] [Related]
8. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
[TBL] [Abstract][Full Text] [Related]
9. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
10. Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation.
Ala-Houhala MJ; Karppinen T; Vähävihu K; Kautiainen H; Dombrowski Y; Snellman E; Schauber J; Reunala T
Acta Derm Venereol; 2014 Mar; 94(2):146-51. PubMed ID: 23995795
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone receptor-1 is increased in mast cells in psoriasis and actinic keratosis, but not markedly in keratinocyte skin carcinomas.
Haimakainen S; Harvima IT
Exp Dermatol; 2023 Oct; 32(10):1794-1804. PubMed ID: 37602923
[TBL] [Abstract][Full Text] [Related]
12. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
13. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
16. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
18. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
19. Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders.
Voss KE; Bollag RJ; Fussell N; By C; Sheehan DJ; Bollag WB
Arch Dermatol Res; 2011 Oct; 303(8):591-600. PubMed ID: 21400035
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D enzymes (CYP27A1, CYP27B1, and CYP24A1) and receptor expression in non-melanoma skin cancer.
Nemazannikova N; Blatch GL; Dass CR; Sinclair R; Apostolopoulos V
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):444-447. PubMed ID: 30668811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
